Premium
Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private equity investors as well as a strategic backer, at least three people aware of the development told VCCircle. The Mumbai-listed company’s plan to seek funding for Biocon Biologics Ltd is part ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
